/NNCSF
NNCSF Stock - Nanosonics Limited
Healthcare|Medical - Instruments & SuppliesOTC
$2.90+0.00%
+$0.00 (+0.00%) • Dec 19
60
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.64
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.50
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $3.19
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NNCSF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.87 – $2.93
TARGET (TP)$3.33
STOP LOSS$2.67
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.75
52W High$3.30
52W Low$1.94
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $198.93M | $170.01M | $167.51M | $119.73M | $101.83M |
| Gross Profit | $155.66M | $132.44M | $125.66M | $86.15M | $74.91M |
| Gross Margin | 78.2% | 77.9% | 75.0% | 72.0% | 73.6% |
| Operating Income | $8.93M | $9.12M | $18.00M | $792,000 | $8.38M |
| Net Income | $20.68M | $12.97M | $19.88M | $3.74M | $8.58M |
| Net Margin | 10.4% | 7.6% | 11.9% | 3.1% | 8.4% |
| EPS | $0.07 | $0.04 | $0.07 | $0.01 | $0.03 |
Company Overview
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NNCSFBeat Rate
82%
Last 11 quarters
Avg Surprise
+37.8%
EPS vs Estimate
Beats / Misses
9/2
Last 12 quarters
Latest EPS
$0.02
Q3 2025
EPS Surprise History
Q4 21
+23.7%
$0.01vs$0.01
Q2 22
+97.8%
$-0.00vs$-0.01
Q4 22
+12.6%
$0.02vs$0.02
Q2 23
+54.3%
$0.02vs$0.01
Q1 24
+51.3%
$0.01vs$0.01
Q3 24
+27.2%
$0.01vs$0.01
Q1 25
+46.7%
$0.02vs$0.01
Q3 25
+13.3%
$0.02vs$0.02
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 17, 2026 | — | — | — | — |
Q3 2025 | Aug 25, 2025 | $0.02 | $0.02 | +13.3% | ✓ BEAT |
Q1 2025 | Feb 19, 2025 | $0.01 | $0.02 | +46.7% | ✓ BEAT |
Q3 2024 | Aug 26, 2024 | $0.01 | $0.01 | +27.2% | ✓ BEAT |
Q1 2024 | Feb 26, 2024 | $0.01 | $0.01 | +51.3% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.01 | $0.02 | +54.3% | ✓ BEAT |
Q4 2022 | Dec 31, 2022 | $0.02 | $0.02 | +12.6% | ✓ BEAT |
Q2 2022 | Jun 30, 2022 | $-0.01 | $-0.00 | +97.8% | ✓ BEAT |
Q4 2021 | Dec 31, 2021 | $0.01 | $0.01 | +23.7% | ✓ BEAT |
Q2 2021 | Jun 30, 2021 | $0.01 | $0.02 | +191.2% | ✓ BEAT |
Q4 2020 | Dec 31, 2020 | $0.01 | $0.00 | -71.9% | ✗ MISS |
Q2 2020 | Jun 30, 2020 | $0.01 | $0.01 | -30.3% | ✗ MISS |
Q4 2019 | Dec 31, 2019 | — | $0.01 | — | — |
Q2 2019 | Jun 30, 2019 | — | $0.01 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.01 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.00 | — | — |
Q4 2017 | Dec 31, 2017 | — | $0.00 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.01 | — | — |
Q4 2016 | Dec 31, 2016 | — | $0.06 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NNCSF
What is NNCSF's current stock price?
Nanosonics Limited (NNCSF) is currently trading at $2.90 per share. The stock has moved +0.00% today.
What is the analyst price target for NNCSF?
No analyst price targets are currently available for this stock.
What sector is Nanosonics Limited in?
Nanosonics Limited operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the OTC exchange.
What is NNCSF's market cap?
Nanosonics Limited has a market capitalization of $0.88 billion, making it a small-cap company.
Does NNCSF pay dividends?
No, Nanosonics Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorARRJF
Arjo AB (publ)
$3.35
Mkt Cap: $0.9B
HGYMF
Hogy Medical Co.,Ltd.
$34.99
Mkt Cap: $0.8B
LFTSF
LifeTech Scientific Corporation
$0.23
Mkt Cap: $1.0B
PHCI
Panamera Holdings Corporation
$8.31
Mkt Cap: $0.7B
SAFLF
Safilo Group S.p.A.
$2.20
Mkt Cap: $0.9B
SAFLY
Safilo Group S.p.A.
$4.00
Mkt Cap: $1.2B
SMSZF
SMS Co., Ltd.
$8.56
Mkt Cap: $0.7B
TDVXF
Tobii Dynavox AB (publ)
$10.99
Mkt Cap: $1.2B
TGLVY
Top Glove Corporation Bhd.
$0.60
Mkt Cap: $1.2B
TSUSF
Tsuruha Holdings Inc.
$17.25
Mkt Cap: $4.2B
Explore stocks similar to NNCSF for comparison